CAT

E130569

The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for assessing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.

All labels observed (1)

Label Occurrences
CAT canonical 3

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf European Union agency body ⓘ
regulatory body ⓘ
scientific committee ⓘ
abbreviation CAT ⓘ
country European Union ⓘ
domain advanced therapy medicinal products ⓘ
gene therapy ⓘ
regenerative medicine ⓘ
somatic cell therapy ⓘ
tissue-engineered products ⓘ
formedBy European Union legislation ⓘ
hasAcronym CAT ⓘ
hasMemberType members appointed by the European Commission ⓘ
members nominated by EU Member States ⓘ
scientific experts ⓘ
inception 2009 ⓘ
jurisdiction European Union ⓘ
languageOfWorkOrName English ⓘ
legalBasis Regulation (EC) No 1394/2007 ⓘ
Regulation (EC) No 726/2004 ⓘ
locatedIn Amsterdam ⓘ
Netherlands ⓘ
parentOrganization European Medicines Agency ⓘ
partOf European Medicines Agency ⓘ
providesGuidanceOn clinical trials of advanced therapies ⓘ
development of advanced therapy medicinal products ⓘ
quality and safety requirements for advanced therapies ⓘ
regulates advanced therapy medicinal products in the EU ⓘ
role advises on certification of quality and non-clinical data for advanced therapies ⓘ
advises on classification of advanced therapy medicinal products ⓘ
assesses advanced therapy medicinal products ⓘ
prepares draft opinions on advanced therapy medicinal products ⓘ
provides scientific expertise on advanced therapies ⓘ
supports development of advanced therapy medicinal products in the EU ⓘ
subjectOf European Medicines Agency documentation ⓘ
supervises evaluation of marketing authorisation applications for advanced therapy medicinal products ⓘ
topic biotechnology ⓘ
gene and cell therapies ⓘ
medicines regulation ⓘ
typeOfAdvancedTherapiesAssessed gene therapy medicinal products ⓘ
somatic cell therapy medicinal products ⓘ
tissue-engineered products ⓘ
website https://www.ema.europa.eu/en/committees/committee-advanced-therapies-cat ⓘ
worksWith Committee for Medicinal Products for Human Use ⓘ
Committee for Orphan Medicinal Products ⓘ
Pharmacovigilance Risk Assessment Committee ⓘ

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Committee for Advanced Therapies → abbreviation → CAT ⓘ
subject linked to: CAT
Committee for Advanced Therapies → hasAcronym → CAT ⓘ
subject linked to: CAT